Author Archives: Sarah Chapman
In this blog for people wanting to quit smoking, Sarah Chapman shares new Cochrane evidence on the effectiveness of nicotine replacement therapy.
Sarah Chapman looks at the latest Cochrane evidence on approaches to preventing seasonal affective disorder (SAD).
Here's a taste of a workshop exploring meaningful consumer engagement in Cochrane, from Cochrane UK and Cochrane Ireland's 2019 symposium.
Sarah Chapman looks at Cochrane evidence on interventions for dysphagia in people with dementia and after stroke.
Sarah Chapman looks at new Cochrane evidence on two treatments for hip and knee osteoarthritis: paracetamol and exercise.
Sarah Chapman looks at Cochrane evidence on the benefits and harms of pregabalin for neuropathic pain and reflects on experience of finding a balance between them.
Sarah Chapman looks at the latest evidence on vitamin and mineral supplements for preventing dementia or at least slowing cognitive decline. Can they really help?
To end the year on Evidently Cochrane, we have dug into a cabinet of medical curiosities and invite you to take our quiz.
As 2018 nears its close, we take a look back to find the top ten most popular Evidently Cochrane blogs published this year.
In this blog, Sarah Chapman looks at the Cochrane evidence for surgical and non-surgical treatments for carpal tunnel syndrome (CTS).
Sarah Chapman looks at the Cochrane evidence for aspects of routine dental care. Something to smile about? Or are there big gaps...?
November is Prematurity Awareness Month and Sarah Chapman shares new Cochrane evidence that omega-3 supplementation can reduce the risk of premature birth